Championing Healthy Public Policy for Older Adults Living with HIV in Canada.
Please consider joining Realize for one of three upcoming online consultations on Championing Healthy Public Policy for Older Adults Living with HIV in Canada.
These online consultations are open to people living with HIV, service providers, health professionals, researchers, policy makers and others with a shared interest in these issues.
Please consider joining Realize for one of three upcoming online consultations on Championing Healthy Public Policy for Older Adults Living with
From Uganda, Matovu William's first article as a regular contributor to PositiveLite.com discusses the many benefits of antiretroviral theraoy (ART).
According to UNAIDS, there were approximately 36.7 million people worldwide living with HIV/AIDS at the end of 2016. Of these, 2.1 million were children (<15 years old). As of July 2017, 20.9 million people living with HIV were accessing antiretroviral therapy (ART) globally, up from 15.8 million in June 2015, 7.5 million in 2010, and less than one million in 2000.
HIV treatment known as Antiretroviral Therapy (ART) is medication which is given to HIV positive people to treat HIV but it do
“Mom, I’m HIV-positive.”
When I hear those words,
I want to grab all the best experts and latest practices,
to advocate for human rights and access to care,
and to reject HIV criminalization.
But most of all, I want to hold you close in a big hug.
I want you to know
that you are loved
no less than you have always been
Your strengths can’t be taken from you--
You flash with energy even while standing still.
You excel in languages,
and in your studies.
What are yo
Add your voice and endorse our call to Eliminate hepatitis C in Canada at ctac.ca/EliminateHepC
Did you know that an estimated 220,000 – 245,000 Canadians are infected with hepatitis C and that around 44% of those individuals are unaware of their status?
Hepatitis C is curable, and although Canada has signed up to the World Health Organisation’s target to eliminate viral hepatitis as a public health threat by 2030, we aren't on course to achieve it.
That's why CTAC needs your help!
“We found that about 1 in 8 patients has undiagnosed and untreated hypertension,” write the researchers. From AIDSmap, Michael Carter reports.
There is a high prevalence of hypertension among HIV-positive patients in the United States and many of these individuals are not receiving hypertensive therapy, investigators report in Clinical Infectious Diseases. Overall, 42% of patients were classified as hypertensive and 13% of these patients were undiagnosed with a further 26% with uncontrolled high blood pressure despite therapy.
“We found that about 1 in 8 patients has undiagnosed and untreated hypertension,” write the researc
A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.
“It’s believed that cognitive function decreases in many of those with HIV partly due to chronic inflammation that occurs in the brain,” said Norbert Kaminski, lead author of the study, now published in the journal AIDS. “This happens because the immune sys
Scepticism among healthcare providers, patients and pharmacists about the safety and efficacy of generic medications is an important barrier. From AIDSmap, Keith Alcorn reports.
The potential savings from prescribing generic antiretrovirals predicted by economic models may be overstated and numerous barriers need to be overcome to bring down the cost of HIV treatment in higher-income countries, according to the findings of several recently-published analyses.
Switching to cheaper generic versions of some antiretrovirals has been proposed as a means of freeing up money to treat more people with HIV in the United States and other higher-income countries where generics
Study finds strong links between PrEP disruptions and intimate partner violence in Kenya and Uganda. Combined interventions could be key to improving adherence and linking victims to support services. From Avert.org, Francesca Harrington-Edmans reports.
Photo credit: istock/znm
People who experience intimate partner violence (IPV) are more likely to miss doses of pre-exposure prophylaxis (PrEP), in Kenya and Uganda, according to new findings published in the Journal of Acquired Immune Deficiency Syndromes (JAIDS).
The study, which recruited participants from four sites across Uganda and Kenya where PrEP was being offered
From The Conversation, guest author Laura Bisaillon on rampant HIV discrimination through the immigration process.
Are you kidding me? With nearly four decades under our collective belts of global experience working on HIV and AIDS, we are past considering it acceptable to link someone’s health status with their perceived sexual “moral values.”
Such were my thoughts after reading and reflecting on an article in The Toronto Star this month: “Decision-maker slammed as ‘Moral Police’ for refusing immigration to HIV-positive man.”
I have researched medical inadmissibility decision-making and
From Overland, guest author Daniel Reeders: "... messages on sexual health almost invariably focus on sex rather than health."
Image credit: Reginald Mount, ‘The easy girlfriend’ (poster), Norwich: Her Majesty’s Stationery Office, 1943-44. This file comes from Wellcome Images, a website operated by Wellcome Trust, a global charitable foundation based in the United Kingdom. Refer to Wellcome blog post (archive).
This article by Daniel Reeders previously appeared at Overland, here.
Two or three times a year, there’ll be a major conference on sexual health, or a report released on how many new sexually tr
Indigenous, Latino, bisexual and single men less likely to be aware of newly publicly-funded HIV prevention medication
(Vancouver, January 31, 2018) A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) - an HIV prevention drug recently made available at no charge to British Columbians at risk of HIV - according to the Momentum Health Study at the BC Centre for Excellence in HIV/AIDS.
“Gay, bisexual, MSM and other MSM in Canada accounted for 56.8% of all new cases of HIV in Canada,” says research scientist, Nathan Lachowsky. “Incre
Closures have taken place across central London and remaining clinics across the capital are facing unmanageable demands. From the Evening Standard, Eleanor Rose reports.
Testing: Digital services will allow people to carry out tests at home, but the rollout has been delayed.
To read the complete story by Eleanor Rose, visit The Evening Standard, here.
Up to 600 people per week are being turned away from oversubscribed sexual health clinics at one of London’s NHS trusts, an expert has warned. Dr Mark Lawton of the British Association of Sexual Health and HIV said the data showing hundreds of people are being turned away from clinic at Guy’s and St Tho
The breadth of data being collected is intended to help answer the wide range of questions about what “real-world” PrEP use looks like in the province. Jack Mohr of the Ontario PrEP Cohort Study has this report.
After years spent waiting, more widespread access to Pre-Exposure Prophylaxis (PrEP) in Ontario finally seems to be taking shape. Health Canada approval for generic forms of tenofovir disoproxil fumarate/emtricitabine (the drug combination used for PrEP) has drastically decreased out of pocket costs for PrEP. This development, along with concerted lobbying from HIV activists, also led to the addition of PrEP to the Ontario Drug Benefit formulary in September 2017. While these changes don’t